Don’t Miss BMY’s Breakout!

The rotation beneath the market’s headline indexes is becoming harder to ignore, particularly as biotech and pharma names begin asserting themselves as new sources of strength. One of the more constructive charts in that group is Bristol Myers Squibb (BMY), which has been building higher highs since its trend turned positive late last year. BMY is now breaking into fresh 52-week highs while maintaining a PowerTrend Buy signal, with its 1-Month price trading above the 10-Month SMA since the crossover at the end of November 2025. For traders, that puts BMY in a clear uptrend and makes its relative strength within the biotech and pharma rotation particularly worth watching.

⏳ Still waiting for your trades to deliver? The FREE 5-Day Cash Flow Trade Report shows you a strategy designed around shorter-term opportunities—Click Here to Claim Your Free Report! 💰🔥

The cleanest way to participate is through buying the shares, but traders looking to put less capital at risk could consider expressing the bullish view through a slightly in-the-money call. That approach gives the position more leverage, meaning a relatively modest move in the stock can have a much larger percentage impact on the option’s value, while the upfront premium defines the capital at risk. In the hypothetical example provided, a 10% rise in BMY by expiration could translate into approximately 108.4% profit potential on the call, though that result is not guaranteed.

Finding strong setups is one thing; consistently identifying where to put new capital to work is another, especially if your goal is to create another potential income stream from the markets. That’s why I created my Weekly Profit Opportunity Newsletter, my personal newsletter where I spend each weekend hunting for the strongest setups I can find and deliver the full technical breakdown and trade plan to subscribers. Of course, not all trade ideas will be mega winners, but with more than 90% of recent setups giving members a chance to profit this is an opportunity worth your attention. Today you can get started for just $1 for your first month—join the trial today and see what’s on my radar next.

Wishing You the Best in Investing Success,